Here we report the nucleotide sequence of pabC, including a portion of a sequence of a downstream open reading frame that may be cotranscribed with pabC. A disruption ofpabC was constructed and transferred to the chromosome, and the pabC mutant strain required PABA for growth. The deduced amino acid sequence of ADC lyase is similar to those of Bacilus subtilis PabC and a number of amino acid transaminases. Aminodeoxychorismate lyase purified from a strain harboring an overproducing plasmid was shown to contain pyridoxal phosphate as a cofactor. This finding explains the similarity to the transaminases, which also contain pyridoxal phosphate. Expression studies revealed the size of the pabC gene product to be -30 kDa, in agreement with that predicted by the nucleotide sequence data and approximately half the native molecular mass, suggesting that the native enzyme is dimeric.
In Escherichia coli, the aromatic pathway branch point precursor chorismate is converted to the following compounds and thereby committed to the corresponding pathways: anthranilate (tryptophan), 4-amino-4-deoxychorismate, or ADC (p-aminobenzoate [PABA] and folate), prephenate (tyrosine and phenylalanine), isochorismate (menaquinone and enterobactin), and p-hydroxybenzoate (ubiquinone).
An evolutionary relationship has been suggested for some of the chorismate-converting proteins because of similarities in the amino acid sequences. For example, the reactions that commit chorismate to anthranilate and ADC are catalyzed by two enzymes, anthranilate synthase and ADC synthase, each of which comprises two dissimilar subunits. One subunit, component I, converts chorismate and ammonia to a product, while the second subunit, component II, confers the ability to use glutamine as a source of ammonia. DNA sequence analysis revealed similarities between the two components I and the two components II, suggesting that pabB and trpE and thatpabA and trpG(D) have evolved from a common ancestor (4, 12) . Also, component I of each enzyme was shown to be similar to isochorismate synthase, which converts chorismate to isochorismate (20) . These similarities have been interpreted to reflect not only an ancestral relationship but also presumably a relationship in the catalytic mechanisms used by these enzymes.
Unlike anthranilate, PABA is synthesized in E. coli from chorismate and glutamine in two steps catalyzed by two separate enzymes (19) . The two subunits of ADC synthase, encoded bypabA andpabB, are required to synthesize ADC from chorismate and glutamine. ADC lyase, encoded by pabC, converts ADC to PABA and pyruvate (1, 6, 30, 31, * Corresponding author. 34 ). While in vitro data so far support a two-step reaction, it remains possible that the proteins exist in a ternary complex in vivo and that ADC synthase and ADC lyase remain active when separated. ADC lyase has been purified to homogeneity, and oligonucleotides designed from the N-terminal amino acid sequence have been used to clone and map the pabC gene from E. coli (6) . While this preparation was the first homogeneous preparation of this protein from any organism, a putative pabC gene had been identified in Bacillus subtilis as part of an apparent folate operon (27) . Of the three genes necessary for PABA biosynthesis in B. subtilis, two are highly similar to E. coli pabA and pabB.
To further our understanding of the mechanism of action of ADC lyase in E. coli, we have subcloned and sequenced the pabC gene and further characterized ADC lyase. E. coli pabC is similar to B. subtilispabC. We show that ADC lyase contains a pyridoxal phosphate cofactor. Furthermore, a strain that is deficient inpabC exhibits a PABA requirement.
MATERIALS AND METHODS
Bacterial strains and plasmids. The genotypes and sources of the strains used in this work are as follows: BN102 (trpA33 Nalr) (18) ; BN117 [his-4proA2 argE3 rpsL 704pheA1 tyrA4 AtrpEA2 pabAl pabB::Kn trpR(TnlO)] (19); DH5aF' [supE44 AlacU169(4801acZAM15) hsdRJ7 recAl end4l gyrA96 thi-1 reLA1], laboratory collection; JC7623 (end recB21 recC22 sbcB15 thr-1 proA2 argE3 leu-6 his-4 thi-1 lacY ara-14 mtl-l xyl-5 galK2 rpsL31 te-x-33 sup-37), laboratory collection; MG1655 (prototroph) (26) ; and MC1000 [A(araAIOC-leu)7697 apaDJ39 A(lacIPOZY-lacIPOZA)X74 strA galUgalK], Malcolm Casadaban. pGP1-2 was obtained from Stan Tabor (28) ; pMB2190, which contains a kanamycin resistance cassette, was obtained from Malcolm Casad-aban; pMK2004 (11) was from our laboratory collection; and pBSII SK+ was obtained from Stratagene.
Sequence analysis. The method of Henikoff (7) was used to generate nested deletions in pJMG30 (see Fig. 1 ). E. coli DH5aF' was transformed with deletion plasmids, and Apr colonies were selected. Plasmid DNA was prepared by the boiling method (8) . Plasmids were screened for insert length and for retention of the BssHII sites at either end of the insert. Plasmids chosen for sequence analysis were prepared in larger quantities by the boiling method with modifications (33) pabC-specific probes were generated by end labelling of polymerase chain reaction amplification products as described previously (23) . Amplification products were generated from two successive rounds of polymerase chain reaction amplification with primers deduced from the N-terminal sequence of ADC lyase. Both rounds consisted of 30 cycles with the following parameters: denaturation at 94°C for 1 min; annealing atx°C (see below) for 2 min; and extension at 72°C for 3 min. In round one, x = 55°C, the template was 1 ,ug of E. coli BN102 chromosomal DNA, and the primers were 0.77 nmol of BPN113 [5'-AA(T,C)TGNGT(G,A,T) ATNC(G,T)(G,A)TC-3'] and 0.19 nmol of BPN114 [5'-AT GTT(T,C)(T,C)TNAT(A,T,C)AA(T,C)GG-3']. Additional reaction components were those recommended by the manufacturer for use with a Perkin-Elmer/Cetus thermal cycler. Reaction products were subsequently fractionated on 12% polyacrylamide gels, and the desired 63-bp band was eluted (23) . In round two, x = 50°C, the template was approximately 0.5 ng of the eluted 63-bp band, and the primers were 0.77 nmol of BPN113 and 0.13 nmol of BPN110 [5'-AA(T,C)GGNCA(T,C)AA(G,A)CA(G,A)GA-3']. Reaction products from round two were purified by isopropanol precipitation prior to end labelling. The final product from round two was 50 bp in length.
Determination of the pyridoxal phosphate cofactor. ADC lyase was isolated from BN117 containing pJMG30, which overproduces ADC lyase. Cells were grown for 24 h to enhance the yield of plasmid-encoded ADC lyase. The protein was purified as described previously, except that the Superose 12 column was omitted (6) . The purified enzyme (0.36 mg, 1 ml), judged greater than 95% pure by polyacrylamide gel electrophoresis, was dialyzed against R buffer (50 R buffer containing 5 mM sodium borohydride and extensively against the same buffer lacking sodium borohydride. The spectrophotometric properties and the ADC lyase activities of the treated and untreated proteins were determined.
Cysteine reacts with pyridoxal phosphate to form an adduct with a characteristicA330 (24), a fact that allowed the determination of the molar ratio of the pyridoxal phosphate cofactor to the ADC lyase subunit. Purified ADC lyase (0.2 ml, 0.29 mg) or standard samples of pyridoxal phosphate (0.2 ml) were mixed with 1 ml of 200 mM cysteine (in 10 mM HCl). Samples were incubated at room temperature for 10 min, heated at 65°C for 10 min, and permitted to cool prior to the determination of the A330-Nucleotide sequence accession number. The nucleotide sequence of pabC has been deposited in GenBank and has been assigned accession number M93135.
RESULTS
Subcloning of pabC. Maps of relevant plasmids are provided in Fig. 1 . pabC was originally isolated as pJMG1, a pACYC184 derivative containing a 7.5-kb EcoRI fragment obtained from lambda clone 14C1 (6, 13 
Nucleotide sequence of pJMG30 (excluding the sequence originating from pMK2004). The sequence representing the putative ribosome binding site upstream of pabC is underlined. The amino acid sequence deduced from the nucleotide sequence is indicated by standard one-letter abbreviations, placed above the first nucleotide of the corresponding codon.
terminus of ADC lyase was thus localized to a 1.7-kb BglII-PstI fragment of pJMG1 (Fig. 1) .
To subclone pabC, we cut pJMG1 DNA with BglII and PstI and ligated it with BamHI-PstI-restricted pMK2004. Ligation mixtures were transformed into E. coli DH5aF'. Twelve Kanr AmpS colonies were isolated, and restriction analysis revealed that 2 of these contained a 1.7-kb insert. Lysates of cells containing one of these clones, pJMG20, contained large amounts of ADC lyase, as determined by an enzyme assay.
For further work, pabC was subcloned into pBSII SK+. PstI-SalI-digested pJMG20 was ligated with PstI-SalI-digested pBSII K+. Following transformation into E. coli DHSaF', 15 Apr Lac-colonies were selected. Restriction analysis indicated that 11 of these contained the desired insert. Lysates of cells containing one of these clones, pJMG30, contained large amounts of ADC lyase.
Sequence analysis. Except for the fragment derived from pMK2004, the insert of clone pJMG30 was sequenced in its entirety on both DNA strands and is shown in Fig. 2 the resultant strain was designated BN1044. All Knr transformants required PABA for growth on minimal medium.
Identification of pyridoxal phosphate as a cofactor of ADC lyase. Highly purified and concentrated ADC lyase was bright yellow; the spectrum is shown in Fig. 4 . Extensive dialysis of the enzyme against R buffer caused no loss of ADC lyase activity, while incubation of the purified enzyme with added pyridoxal phosphate, pyridoxal, pyridoxamine, or pyridoxamine phosphate resulted in no increase in activity (5). Reduction of the enzyme with sodium borohydride altered the spectrum and abolished ADC lyase activity (Fig.  4) . The spectra of the reduced and native enzymes are similar to those of known pyridoxal phosphate-dependent proteins, including rabbit liver serine hydroxymethyltransferase (24, 25) and E. coli 2-amino-3-ketobutyrate coenzyme A ligase (16) . We attempted to resolve native ADC lyase into the apoprotein and free cofactor by dialysis against hydroxylamine or cysteine. While some spectrophotometric changes occuffed with the treatment of ADC lyase with both compounds, no more than 40% activity was lost, and the addition of pyridoxal derivatives to the treated enzyme did not restore ADC lyase activity.
Pyridoxal phosphate forms an adduct with cysteine that absorbs at 330 nm (24) , and this property was used to estimate the amount of pyridoxal phosphate bound per mole of ADC lyase holoenzyme. Standard solutions of pyridoxal phosphate (0 to 600 ,uM) or of ADC lyase holoenzyme (0.286 mg; judged 95% pure by SDS-polyacrylamide gel electrophoresis) were mixed with cysteine as described in Materials and Methods, and the A330 was measured. A linear standard curve was generated from the stock pyridoxal phosphate samples, and by comparison the ADC lyase sample was determined to contain 11.4 nmol of pyridoxal phosphate. Assuming 95% purity of the initial ADC lyase sample and a subunit molecular weight of (21) . The N terminus of the deduced product of the open reading frame downstream of pabC exhibited 46% identity with the first 26 amino acids of E. coli CDPdiacylglycerol pyrophosphatase. Since this enzyme is associated with the membrane, it is possible that the downstream open reading frame product is also membrane bound (10) . No other significant similarity was found.
The sequence of pabC was used to search for similar proteins in the GenBank data base (21) . Maximum identity (32%) occurred with putative PabC of B. subtilis (Fig. 5) (27) . The predicted product of B. subtilispabC (31 kDa) is slightly larger than the E. coli protein (29.7 kDa) .
E. coli PabC also showed 23% identity with Bacillus sphaericus YM-1 D-alanine aminotransferase, 23% identity with Salmonella typhimurium branched-chain amino acid aminotransferase, and 22% identity with E. coli branchedchain amino acid aminotransferase. In each case, the similarities were fairly evenly distributed throughout the sequence and were probably the result of a pyridoxal phosphate requirement of each of these proteins. Interestingly, B. sphaericus YM-1 D-alanine aminotransferase lysine 145, which binds pyridoxal phosphate, corresponds to lysine 140 in E. coli PabC (29) . This region is one of high similarity between the two proteins, with 7 of 11 amino acids being identical. By analogy, lysine 140, one of six lysines in E. coli ADC lyase, may be involved in the binding of pyridoxal phosphate.
E. colipabC exhibited no similarity to trpE, although ADC lyase catalyzes a reaction similar to a portion of the reaction catalyzed by the trpE gene product-the aromatization of an aminated chorismate intermediate, with the concomitant liberation of pyruvate. The intermediate analogous to ADC in anthranilate biosynthesis, 2-amino-2-deoxyisochorismate, has been synthesized independently by two groups (22, 30) . Both groups showed that Serratia marcescens anthranilate synthase component I was kinetically competent in converting the intermediate compound to anthranilate, suggesting that this intermediate might be an enzyme-bound intermediate in the synthesis of anthranilate synthase. In addition, certain anthranilate synthase mutants accumulated aminodeoxyisochorismate, further supporting the role of this intermediate in anthranilate synthesis (15) .
Unlike anthranilate synthase, ADC lyase contains a tightly bound pyridoxal phosphate cofactor. We have postulated a mechanism for the catalysis of the ADC lyase reaction in Fig. 6 . Initially, ADC would bind in an imine linkage to the cofactor. An active-site base would abstract the alpha hydrogen, a process that would be stabilized by resonance with the pyridoxal phosphate. As shown, aromatization of the ring would be concomitant with release of the pyruvate. The e-amino group of an active-site lysine could attack the PABA-pyridoxal phosphate imine to liberate PABA and restore the initial enzyme-coenzyme aldimine.
Previously proposed mechanisms for the ADC lyase reaction have not involved the use of any cofactor (32) (chorismate is converted to pyruvate and p-hydroxybenzoate), except that the substrate contains a hydroxyl group where ADC contains an amino group. In the accompanying paper (17), we describe the purification and characterization of chorismate lyase. We also report on the nucleotide sequence of ubiC and show that there is no significant similarity between ADC lyase and chorismate lyase. Therefore, ADC lyase appears to be unique among the enzymes that utilize chorismate or chorismate derivatives in requiring pyridoxal phosphate.
